Healthy Lifestyle in Adults With ADHD
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 253
- 试验地点
- 1
- 主要终点
- Comparison of ADHD and control subject health habits will be assessed by subject-rated questionnaires and health measures, such as vital signs and blood draw results.
研究概览
简要总结
The purpose of this study is to understand the relationship between ADHD and the overall health of someone with ADHD. People who have ADHD have trouble paying attention, concentrating, organizing, and planning. They may have trouble in school, at work, and at home. The investigators are interested in finding out whether these difficulties have had any influence in the past, current, or future health problems of someone with ADHD. About 100 people with ADHD and 100 people without ADHD will take part in this research study, all through Massachusetts General Hospital (MGH).
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •ADHD Subjects
- •Signed written informed consent to participate in the study.
- •Age: 18 - 60 (inclusive).
- •Current diagnosis of DSM-IV ADHD by structured interview. Late age of onset acceptable for participation provided ADHD symptoms meet full criteria currently.
- •Control Subjects
- •Signed written informed consent to participate in the study.
- •Age: 18 - 60 (inclusive).
- •Subjects must have <3 symptoms in each domain (Inattention and Hyperactive/Impulsive) and <5 total symptoms in both domains on the DSM-IVADHD module of the structured interview.
排除标准
- •Diagnosis of any psychotic disorder or Autism.
- •Mental impairment as evidenced by a Full Scale I.Q. less than
- •Major sensorimotor handicaps such as deafness or blindness.
- •Subject currently taking antipsychotic medication or mood stabilizers.
- •Inadequate command of the English language.
结局指标
主要结局
Comparison of ADHD and control subject health habits will be assessed by subject-rated questionnaires and health measures, such as vital signs and blood draw results.
时间窗: 1 time
次要结局
未报告次要终点
研究者
Thomas J. Spencer, MD
Associate Chief, Clinical and Research Program, Pediatric Psychopharmacology
Massachusetts General Hospital